Single step enantioselective process for the preparation of 3-substituted chiral phthalides

US9505733B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9505733-B2
Application numberUS-201514694588-A
CountryUS
Kind codeB2
Filing dateApr 23, 2015
Priority dateNov 18, 2011
Publication dateNov 29, 2016
Grant dateNov 29, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention discloses single step, highly enantioselective catalytic oxidative cyclization process for the synthesis of 3-substituted chiral phthalides. In particular, the invention discloses asymmetric synthesis of chiral phthalides via synergetic nitrile accelerated oxidative cyclization of o-cyano substituted aryl alkenes in high yield and enantiomeric excess (ee) in short reaction time. Also, disclosed herein is “one-pot” asymmetric synthesis of biologically important natural compounds having 3-substituted chiral phthalide structural framework in the molecule.

First claim

Opening claim text (preview).

The invention claimed is: 1. A synthesis of compound (3) comprising (a) reacting an o-cyano substituted aryl alkene of Formula I with AD-mix-β in the presence of a solvent at room temperature ranging between 25-35° C. for a period ranging between 3-7 h to form a cyclic amino ether (b) hydrolyzing the cyclic amino ether with water to form the lactone of Formula II; wherein AD-mix-β comprises potassium osmate K 2 OsO 2 (OH) 4 ; potassium ferricyanide K 3 Fe(CN) 6 ; potassium carbonate; and chiral ligand (DHQD) 2 PHAL; and wherein R 1 , R 2 , R 3 and R4 are hydrogen; and R 5 is C 4 H 9 to form compound (21) (c) carrying out Barton-Mccombie deoxygenation of compound (21) with 1,1-thiocarbonyl diimidazole in the presence of dichloromethane as solvent at 25-35° C. for 10-14 h followed by treatment with tributyltinhydride in the presence of catalytic amount of azobisisobutyronitrile for 20-40 min to obtain compound (3). 2. A synthesis of compound (2a) comprising (a) reacting an o-cyano substituted aryl alkene of Formula I with AD-mix-β in the presence of a solvent at room temperature ranging between 25-35° C. for a period ranging between 3-7 h to form a cyclic amino ether (b) hydrolyzing the cyclic amino ether with water to form the lactone of Formula II; wherein AD-mix-β comprises osmate K 2 OsO 2 (OH 4 ); potassium ferricyanide K 3 Fe(CN) 6 ; potassium carbonate; and chiral ligand (DHQD) 2 PHAL; and wherein R 1 and R 3 are hydrogen, R 2 and R 4 are —OMe, and R 5 is unsubstituted phenyl; to form compound (19) (c) adding BBr3 and an organic solvent to compound (19) followed by stirring at 10° C. to 25° C. for 6-8 h to obtain compound (2a). 3. A synthesis of compound (20) comprising (a) reacting an o-cyano substituted aryl alkene of Formula I with AD-mix-β in the presence of a solvent at room temperature ranging between 25-35° C. for a period ranging between 3-7 h to form a cyclic amino ether (b) hydrolyzing the cyclic amino ether with water to form the lactone of Formula II; wherein AD-mix-β comprises potassium osmate K 2 OsO 2 (OH) 4 ; potassium ferricyanide K 3 Fe(CN) 6 ; potassium carbonate; and chiral ligand (DHQD) 2 PHAL; and wherein R 1 and R 3 are hydrogen, R 2 and R4 are —OMe and R 5 is —Me; to form compound (18) (c) adding BBr3 and an organic solvent to compound (18), followed by stirring at 10° C. to 25° C. for 6-8 h to obtain compound (20).

Assignees

Inventors

Classifications

  • Naphthofurans; Hydrogenated naphthofurans · CPC title

  • Ortho-condensed systems · CPC title

  • C07D307/88Primary

    with one oxygen atom directly attached in position 1 or 3 · CPC title

  • Asymmetric syntheses · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9505733B2 cover?
The present invention discloses single step, highly enantioselective catalytic oxidative cyclization process for the synthesis of 3-substituted chiral phthalides. In particular, the invention discloses asymmetric synthesis of chiral phthalides via synergetic nitrile accelerated oxidative cyclization of o-cyano substituted aryl alkenes in high yield and enantiomeric excess (ee) in short reaction…
Who is the assignee on this patent?
Council Scient Ind Res
What technology area does this patent fall under?
Primary CPC classification C07D307/88. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).